Shivinder plans to take up full-time sewa at Radha Soami Satsang Beas (RSSB), a spiritual organisation headquartered near Amritsar, Punjab, the company said.
“Having spent almost two decades setting up and running Fortis, our mission of saving and enriching lives is an integral part of my being. Over time, this has inspired me to do more direct service and give back to society a little of what I have received in abundance,” Shivinder said.
The two brothers, who jointly set up and grew the health care business from scratch, together hold 71.33 per cent stake in the company that has a market cap of about Rs 8,000 crore. The company’s stock closed at Rs 175.60 at the BSE, up nearly three per cent from the previous day. The duo also hold a 51 per cent stake in financial services company, Religare, valued at Rs 5,200 crore and own the SRL Diagnostics chain.
The brothers had inherited pharmaceutical company Ranbaxy from father Parvinder Singh (who passed away in 1999), ran it for several years and sold their stake to Japanese buyer Daiichi Sankyo for $4.6 billion in 2008. In April 2014, Sun Pharmaceutical bought Ranbaxy for $4 billion.
Fortis has trimmed its debt by close to Rs 4,600 crore over the past couple of years to less than Rs 1,200 crore, by selling most of the foreign assets it had acquired in the recent years.
It is looking to report profits this year. Fortis reported a consolidated income of Rs 4,089 crore in the year-ended March and a net loss of Rs 144 crore.
The company, which went ahead with a series of foreign acquisitions earlier, now plans to focus less on expansion and more on enhancing services and margins. Therefore, Shivinder’s decision will not have a material impact on operations. In July, the brothers reappointed Bhavdeep Singh as the chief executive, who rejoined the company after four years.
At a time when most Indian business families have split, the Singh brothers continue to share a strong bond. The two draw the same salary and perquisite.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)